BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20823296)

  • 1. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
    Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
    Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
    Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
    Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
    Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
    Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.
    Laczmanska I; Sasiadek MM
    J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
    Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
    Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
    Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
    J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
    Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
    Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
    J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
    Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
    Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
    Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
    Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
    Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
    Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
    IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
    Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
    J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
    Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
    Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of
    Chatzikyriakidou A; Chorti A; Papavramidis T
    In Vivo; 2019; 33(6):2281-2285. PubMed ID: 31662568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.